NASDAQ$OMDA
Omada Health Inc · Q1 2026 earnings
Q1 2026 earnings ·
Briefing
Omada Health Inc Q1 fiscal 2026: $78.0M revenue, $3.0M net loss
for the year ended December 31, 2025, as filed with the SEC on March 6, 2026. up, which beneficially owns more than 5 % of the Company’s outstanding capital stock through Cigna Ventures, LLC. (SEC accession 0001628280-26-032875)
- Revenue: $78.0M
- Net loss: $3.0M
- Diluted EPS: $-0.05
- Operating income: $-4.8M
- Gross profit: $48.7M
Headline financials
Revenue & EPS history
Omada Health Inc · Revenue · Quarterly
$78M
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 3 quarterly earnings reports · overlaid with Q1 2026
-3.9%
Avg return
Earnings day
+0.0%
Avg return
5 days after
-0.9%
Avg return
30 days after
25%
1 / 4 earnings
Positive
+3.3%
Q4 2025
Best reaction
-9.6%
Q1 2026
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -9.6% | -2.3% | — | |
| Q4 2025 | +3.3% | +1.0% | -7.5% | |
| Q3 2025 | -7.1% | -1.9% | -20.0% | |
| Q2 2025 | -2.3% | +3.2% | +24.8% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro